A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)

Grants and Contracts Details

StatusFinished
Effective start/end date2/9/161/31/18

Funding

  • Axovant Sciences Incorporated: $69,139.00